Patient-reported outcomes of autologous serum tears for the treatment of dry eye disease in a large cohort

RECOMMENDED

Dry Eye Disease

Characterization of tear production in subjects with dry eye disease during intranasal tear neurostimulation: Results from two pivotal clinical trials

Ocul Surf.

Sheppard JD, Torkildsen GL, Geffin JA, Dao J, Evans DG, Ousler GW, Wilson J, Baba SN, Senchyna M, Holland EJ

doi: 10.1016/j.jtos.2018.11.009.

Further PublicationsDry Eye Disease

Comparative of meibomian gland morphology in patients with evaporative dry eye disease versus non-dry eye disease

Sci Rep

Crespo-Treviño RR, Salinas-Sánchez AK, Amparo F, Garza-Leon M

doi: 10.1038/s41598-021-00122-y

Macular Diseases

Visual Acuity Outcomes after Anti-Vascular Endothelial Growth Factor Treatment for Neovascular Age-Related Macular Degeneration: Age-Related Eye Disease Study 2 Report Number 19

Ophthalmol Retina.

Keenan TD, Vitale S, Agrón E, Domalpally A, Antoszyk AN, Elman MJ, Clemons TE, Chew EY, Age-Related Eye Disease Study 2 Research Group.

doi: 10.1016/j.oret.2019.06.001.

Dry Eye Disease

The Dry Eye Assessment and Management (DREAM) extension study - A randomized clinical trial of withdrawal of supplementation with omega-3 fatty acid in patients with dry eye disease

Ocul Surf.

Hussain M, Shtein RM, Pistilli M, Maguire MG, Oydanich M, Asbell PA, DREAM Research Group.

doi: 10.1016/j.jtos.2019.08.002.

Predictors of Discordance between Symptoms and Signs in Dry Eye Disease.

Ophthalmology.

Vehof J, Sillevis Smitt-Kamminga N, Nibourg SA, Hammond CJ

doi: 10.1016/j.ophtha.2016.11.008.

Dry Eye Disease

An artificial tear containing flaxseed oil for treating dry eye disease: A randomized controlled trial

Ocul Surf.

Downie LE, Hom MM, Berdy GJ, El-Harazi S, Verachtert A, Tan J, Liu H, Carlisle-Wilcox C, Simmons P, Vehige J

doi: 10.1016/j.jtos.2019.11.004.

Dry Eye Disease

Utility of Tear Osmolarity Measurement in Diagnosis of Dry Eye Disease

Sci Rep.

Tashbayev B, Utheim TP, Utheim ØA, Ræder S, Jensen JL, Yazdani M, Lagali N, Vitelli V, Dartt DA, Chen X

doi: 10.1038/s41598-020-62583-x.

Dry Eye Disease

A Phase 3, Randomized, Double-Masked Study of OTX-101 Ophthalmic Solution 0.09% in the Treatment of Dry Eye Disease

Ophthalmology.

Goldberg DF, Malhotra RP, Schechter BA, Justice A, Weiss SL, Sheppard JD

doi: 10.1016/j.ophtha.

Dry Eye Disease

Efficacy of topical ophthalmic drugs in the treatment of dry eye disease: A systematic literature review

Ocul Surf.

Holland EJ, Darvish M, Nichol KK, Jones L, Karpecki PM

doi: 10.1016/j.jtos.2019.02.012.

Related content

Characterization of tear production in subjects with dry eye disease during intranasal tear neurostimulation: Results from two pivotal clinical trials

Comparative of meibomian gland morphology in patients with evaporative dry eye disease versus non-dry eye disease

Visual Acuity Outcomes after Anti-Vascular Endothelial Growth Factor Treatment for Neovascular Age-Related Macular Degeneration: Age-Related Eye Disease Study 2 Report Number 19

The Dry Eye Assessment and Management (DREAM) extension study - A randomized clinical trial of withdrawal of supplementation with omega-3 fatty acid in patients with dry eye disease

Predictors of Discordance between Symptoms and Signs in Dry Eye Disease.

An artificial tear containing flaxseed oil for treating dry eye disease: A randomized controlled trial

Utility of Tear Osmolarity Measurement in Diagnosis of Dry Eye Disease

A Phase 3, Randomized, Double-Masked Study of OTX-101 Ophthalmic Solution 0.09% in the Treatment of Dry Eye Disease

Efficacy of topical ophthalmic drugs in the treatment of dry eye disease: A systematic literature review